BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7560245)

  • 1. Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and children.
    Reed MD; Yamashita TS; Blumer JL
    J Clin Pharmacol; 1995 Jul; 35(7):658-65. PubMed ID: 7560245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis.
    Burstein AH; Wyble LE; Gal P; Diaz PR; Ransom JL; Carlos RQ; Forrest A
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2024-8. PubMed ID: 7811013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis.
    Jacobs RF; Trang JM; Kearns GL; Warren RH; Brown AL; Underwood FL; Kluza RB
    J Pediatr; 1985 Jun; 106(6):1001-7. PubMed ID: 3998937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation.
    Lindsay CA; Bawdon R; Quigley R
    Pharmacotherapy; 1996; 16(3):458-62. PubMed ID: 8726606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ticarcillin/clavulanate in severely burned patients.
    Adam D; Zellner PR; Koeppe P; Wesch R
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():121-9. PubMed ID: 2606814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
    Woodnutt G; Berry V; Kernutt I; Mizen L
    J Antimicrob Chemother; 1990 Nov; 26(5):695-704. PubMed ID: 2079451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ticarcillin and clavulanic acid given in combination to adult horses by intravenous and intramuscular routes.
    Sweeney RW; Beech J; Simmons RD; Soma LR
    J Vet Pharmacol Ther; 1988 Mar; 11(1):103-8. PubMed ID: 3379659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels and pharmacokinetics of ticarcillin and clavulanic acid in dog following parenteral administration of Timentin.
    Garg RC; Keefe TJ; Vig MM
    J Vet Pharmacol Ther; 1987 Dec; 10(4):324-30. PubMed ID: 3501810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and pharmacokinetics of Timentin in paediatric infections.
    Bégué P; Quiniou F; Quinet B
    J Antimicrob Chemother; 1986 May; 17 Suppl C():81-91. PubMed ID: 3636339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of clavulanic acid and ticarcillin combined.
    Scully BE; Steinman R; Chin NX; Neu HC
    Chemioterapia; 1984 Dec; 3(6):385-9. PubMed ID: 6529781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticarcillin plus clavulanic acid: pharmacokinetic study in renal failure.
    Stathakis C; Bakounsli I; Iatrou C; Boletis J; Kosmidis J
    Chemioterapia; 1987 Jun; 6(2 Suppl):265-7. PubMed ID: 3509408
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacokinetics of ticarcillin/clavulanate acid in neonates.
    Fricke G; Doerck M; Hafner D; Horton R; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():111-20. PubMed ID: 2606813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration to peripheral human lymph of clavulanic acid and ticarcillin.
    Bergan T; Olszewski W; Engeset A
    J Antimicrob Chemother; 1986 Jan; 17(1):97-103. PubMed ID: 3949640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of ticarcillin and clavulanate in foals after intravenous and intramuscular administration.
    Wilson WD; Spensley MS; Baggot JD; Hietala SK; Pryor P
    J Vet Pharmacol Ther; 1991 Mar; 14(1):78-89. PubMed ID: 2038098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of Timentin (ticarcillin and clavulanic acid) across the in vitro perfused human placenta: comparison with other agents.
    Fortunato SJ; Bawdon RE; Swan KF; Bryant EC; Sobhi S
    Am J Obstet Gynecol; 1992 Dec; 167(6):1595-9. PubMed ID: 1471672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of ticarcillin, clavulanic acid and their combination.
    Höffken G; Tetzel H; Koeppe P; Lode H
    J Antimicrob Chemother; 1986 May; 17 Suppl C():47-55. PubMed ID: 3722046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reassessment of ticarcillin/clavulanic acid dose recommendations for infants, children and adults.
    Reed MD
    Pediatr Infect Dis J; 1998 Dec; 17(12):1195-9. PubMed ID: 9877382
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals.
    Woodnutt G; Kernutt I; Mizen L
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1826-30. PubMed ID: 3501702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.